Vir Biotechnology, Inc. VIR Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermInvestments.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s equity method investments?
- Vir Biotechnology, Inc. (VIR) reported equity method investments of $332.97M in Q1 2026.
- How has Vir Biotechnology, Inc.'s equity method investments changed year-over-year?
- Vir Biotechnology, Inc.'s equity method investments increased by 52.6% year-over-year, from $218.14M to $332.97M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.